241 related articles for article (PubMed ID: 23940701)
1. The curcumin analog EF24 targets NF-κB and miRNA-21, and has potent anticancer activity in vitro and in vivo.
Yang CH; Yue J; Sims M; Pfeffer LM
PLoS One; 2013; 8(8):e71130. PubMed ID: 23940701
[TBL] [Abstract][Full Text] [Related]
2. A liposomal formulation of the synthetic curcumin analog EF24 (Lipo-EF24) inhibits pancreatic cancer progression: towards future combination therapies.
Bisht S; Schlesinger M; Rupp A; Schubert R; Nolting J; Wenzel J; Holdenrieder S; Brossart P; Bendas G; Feldmann G
J Nanobiotechnology; 2016 Jul; 14(1):57. PubMed ID: 27401816
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of IkappaB kinase-nuclear factor-kappaB signaling pathway by 3,5-bis(2-flurobenzylidene)piperidin-4-one (EF24), a novel monoketone analog of curcumin.
Kasinski AL; Du Y; Thomas SL; Zhao J; Sun SY; Khuri FR; Wang CY; Shoji M; Sun A; Snyder JP; Liotta D; Fu H
Mol Pharmacol; 2008 Sep; 74(3):654-61. PubMed ID: 18577686
[TBL] [Abstract][Full Text] [Related]
4. EF24 inhibits tumor growth and metastasis via suppressing NF-kappaB dependent pathways in human cholangiocarcinoma.
Yin DL; Liang YJ; Zheng TS; Song RP; Wang JB; Sun BS; Pan SH; Qu LD; Liu JR; Jiang HC; Liu LX
Sci Rep; 2016 Aug; 6():32167. PubMed ID: 27571770
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-33b, upregulated by EF24, a curcumin analog, suppresses the epithelial-to-mesenchymal transition (EMT) and migratory potential of melanoma cells by targeting HMGA2.
Zhang P; Bai H; Liu G; Wang H; Chen F; Zhang B; Zeng P; Wu C; Peng C; Huang C; Song Y; Song E
Toxicol Lett; 2015 May; 234(3):151-61. PubMed ID: 25725129
[TBL] [Abstract][Full Text] [Related]
6. Diphenyl difluoroketone: a curcumin derivative with potent in vivo anticancer activity.
Subramaniam D; May R; Sureban SM; Lee KB; George R; Kuppusamy P; Ramanujam RP; Hideg K; Dieckgraefe BK; Houchen CW; Anant S
Cancer Res; 2008 Mar; 68(6):1962-9. PubMed ID: 18339878
[TBL] [Abstract][Full Text] [Related]
7. The Curcumin Analog EF24 Inhibits Proliferation and Invasion of Triple-Negative Breast Cancer Cells by Targeting the Long Noncoding RNA HCG11/Sp1 Axis.
Duan Y; Chen HL; Ling M; Zhang S; Ma FX; Zhang HC; Lv XA
Mol Cell Biol; 2022 Jan; 42(1):e0016321. PubMed ID: 34780286
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of the NF-κB signaling pathway by the curcumin analog, 3,5-Bis(2-pyridinylmethylidene)-4-piperidone (EF31): anti-inflammatory and anti-cancer properties.
Olivera A; Moore TW; Hu F; Brown AP; Sun A; Liotta DC; Snyder JP; Yoon Y; Shim H; Marcus AI; Miller AH; Pace TW
Int Immunopharmacol; 2012 Feb; 12(2):368-77. PubMed ID: 22197802
[TBL] [Abstract][Full Text] [Related]
9. In vivo and in vitro suppression of hepatocellular carcinoma by EF24, a curcumin analog.
Liu H; Liang Y; Wang L; Tian L; Song R; Han T; Pan S; Liu L
PLoS One; 2012; 7(10):e48075. PubMed ID: 23118928
[TBL] [Abstract][Full Text] [Related]
10. EF24 induces G2/M arrest and apoptosis in cisplatin-resistant human ovarian cancer cells by increasing PTEN expression.
Selvendiran K; Tong L; Vishwanath S; Bratasz A; Trigg NJ; Kutala VK; Hideg K; Kuppusamy P
J Biol Chem; 2007 Sep; 282(39):28609-28618. PubMed ID: 17684018
[TBL] [Abstract][Full Text] [Related]
11. Activation of the p38 pathway by a novel monoketone curcumin analog, EF24, suggests a potential combination strategy.
Thomas SL; Zhao J; Li Z; Lou B; Du Y; Purcell J; Snyder JP; Khuri FR; Liotta D; Fu H
Biochem Pharmacol; 2010 Nov; 80(9):1309-16. PubMed ID: 20615389
[TBL] [Abstract][Full Text] [Related]
12. EF24, a novel curcumin analog, disrupts the microtubule cytoskeleton and inhibits HIF-1.
Thomas SL; Zhong D; Zhou W; Malik S; Liotta D; Snyder JP; Hamel E; Giannakakou P
Cell Cycle; 2008 Aug; 7(15):2409-17. PubMed ID: 18682687
[TBL] [Abstract][Full Text] [Related]
13. Curcumin analog EF24 induces apoptosis via ROS-dependent mitochondrial dysfunction in human colorectal cancer cells.
He G; Feng C; Vinothkumar R; Chen W; Dai X; Chen X; Ye Q; Qiu C; Zhou H; Wang Y; Liang G; Xie Y; Wu W
Cancer Chemother Pharmacol; 2016 Dec; 78(6):1151-1161. PubMed ID: 27787644
[TBL] [Abstract][Full Text] [Related]
14. Design and optimize N-substituted EF24 as effective and low toxicity NF-κB inhibitor for lung cancer therapy via apoptosis-to-pyroptosis switch.
Chen L; Li Q; Zheng Z; Xie J; Lin X; Jiang C; Xu H; Wu X; Wu J; Zhang H
Chem Biol Drug Des; 2019 Jul; 94(1):1368-1377. PubMed ID: 30873716
[TBL] [Abstract][Full Text] [Related]
15. Multiple anticancer activities of EF24, a novel curcumin analog, on human ovarian carcinoma cells.
Tan X; Sidell N; Mancini A; Huang RP; Shenming Wang ; Horowitz IR; Liotta DC; Taylor RN; Wieser F
Reprod Sci; 2010 Oct; 17(10):931-40. PubMed ID: 20693500
[TBL] [Abstract][Full Text] [Related]
16. Hypoxia-mediated sorafenib resistance can be overcome by EF24 through Von Hippel-Lindau tumor suppressor-dependent HIF-1α inhibition in hepatocellular carcinoma.
Liang Y; Zheng T; Song R; Wang J; Yin D; Wang L; Liu H; Tian L; Fang X; Meng X; Jiang H; Liu J; Liu L
Hepatology; 2013 May; 57(5):1847-57. PubMed ID: 23299930
[TBL] [Abstract][Full Text] [Related]
17. The Curcumin Analog EF24 is Highly Active Against Chemotherapy- Resistant Melanoma Cells.
He Y; Li W; Zhang J; Yang Y; Qian Y; Zhou D
Curr Cancer Drug Targets; 2021; 21(7):608-618. PubMed ID: 33655859
[TBL] [Abstract][Full Text] [Related]
18. EF24 induces ROS-mediated apoptosis via targeting thioredoxin reductase 1 in gastric cancer cells.
Zou P; Xia Y; Chen W; Chen X; Ying S; Feng Z; Chen T; Ye Q; Wang Z; Qiu C; Yang S; Liang G
Oncotarget; 2016 Apr; 7(14):18050-64. PubMed ID: 26919110
[TBL] [Abstract][Full Text] [Related]
19. Diphenyl difluoroketone: a potent chemotherapy candidate for human hepatocellular carcinoma.
Liang Y; Yin D; Hou L; Zheng T; Wang J; Meng X; Lu Z; Song X; Pan S; Jiang H; Liu L
PLoS One; 2011; 6(8):e23908. PubMed ID: 21901145
[TBL] [Abstract][Full Text] [Related]
20. Preclinical evaluation of 4-[3,5-bis(2-chlorobenzylidene)-4-oxo-piperidine-1-yl]-4-oxo-2-butenoic acid, in a mouse model of lung cancer xenograft.
Yadav VR; Sahoo K; Awasthi V
Br J Pharmacol; 2013 Dec; 170(7):1436-48. PubMed ID: 24102070
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
